Extending the diversity of cytochrome P450 enzymes by DNA family shuffling

Gene

Volumn 395, Issue 1-2, 2007, Pages 40-48

  Rosic, Nedeljka N ^a   Huang, Weiliang ^a   Johnston, Wayne A ^a   DeVoss, James J ^a   Gillam, Elizabeth M J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

CYP2C; Directed evolution; Heterologous expression; Indigo; Indole metabolism; Molecular breeding

Indexed keywords

CYTOCHROME P450; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

ARTICLE; DNA SHUFFLING; ESCHERICHIA COLI; MULTIGENE FAMILY; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN FOLDING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS;

ANIMALS; BASE SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; DIRECTED MOLECULAR EVOLUTION; DNA PRIMERS; DNA SHUFFLING; ESCHERICHIA COLI; GENE LIBRARY; HEMEPROTEINS; HUMANS; INDOLES; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECOMBINANT PROTEINS; VARIATION (GENETICS);

ESCHERICHIA COLI; MAMMALIA;

EID: 34247626257     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2007.01.031     Document Type: Article

References (40)

1. Abecassis V., Pompon D., and Truan G. High efficiency family shuffling based on multi-step PCR and in vivo DNA recombination in yeast: statistical and functional analysis of a combinatorial library between human cytochrome P450 1A1 and 1A2. Nucleic Acids Res. 28 (2000) E88
2. Bacher J.M., Reiss B.D., and Ellington A.D. Anticipatory evolution and DNA shuffling. Genome Biol. 3 (2002) REVIEWS1021
3. Bell S.G., et al. Molecular recognition in (+)-alpha-pinene oxidation by cytochrome P450cam. J. Am. Chem. Soc. 125 (2003) 705-714
4. Cohen N., Abramov S., Dror Y., and Freeman A. In vitro enzyme evolution: the screening challenge of isolating the one in a million. Trends Biotechnol. 19 (2001) 507-510
5. Crameri A., Raillard S.A., Bermudez E., and Stemmer W.P.C. DNA shuffling of a family of genes from diverse species accelerates directed evolution. Nature 391 (1998) 288-291
6. Cuttle L., et al. Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation. Drug Metab. Dispos. 28 (2000) 945-950
7. Ensley B.D., Ratzkin B.J., Osslund T.D., Simon M.J., Wackett L.P., and Gibson D.T. Expression of naphthalene oxidation genes in Escherichia coli results in the biosynthesis of indigo. Science 222 (1983) 167-169
8. Gillam E.M.J., Baba T., Kim B.R., Ohmori S., and Guengerich F.P. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305 (1993) 123-131
9. Gillam E.M.J., et al. Formation of indigo by recombinant mammalian cytochrome P450. Biochem. Biophys. Res. Commun. 265 (1999) 469-472
10. Gillam E.M.J., Notley L.M., Cai H., De Voss J.J., and Guengerich F.P. Oxidation of indole by cytochrome P450 enzymes. Biochemistry 39 (2000) 13817-13824
11. Glieder A., Farinas E.T., and Arnold F.H. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase. Nat. Biotechnol. 20 (2002) 1135-1139
12. Goldstein J.A., and de Morais S.M. Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4 (1994) 285-299
13. Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J. Biol. Chem. 267 (1992) 83-90
14. Guengerich F.P. Analysis and characterization of enzymes. In: Hayes A.W. (Ed). Principles and Methods of Toxicology (1994), Raven Press, New York 1259-1313
15. Guengerich F.P. Human Cytochrome P450 Enzymes, in Cytochrome P450 (2004), Plenum Press, New York
16. Guengerich F.P., Parikh A., Turesky R.J., and Josephy P.D. Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype. Mutat. Res. 428 (1999) 115-124
17. Guengerich F.P., Sorrells J.L., Schmitt S., Krauser J.A., Aryal P., and Meijer L. Generation of new protein kinase inhibitors utilizing cytochrome P450 mutant enzymes for indigoid synthesis. J. Med. Chem. 47 (2004) 3236-3241
18. Hall B.G. Predicting evolution by in vitro evolution requires determining evolutionary pathways. Antimicrob. Agents Chemother. 46 (2002) 3035-3038
19. Hoessel R., et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat. Cell Biol. 1 (1999) 60-67
20. Joern J.M. DNA Shuffling. In: Arnold F.H., and Georgiou G. (Eds). Methods in Molecular Biology: Directed Evolution Library Creation: Methods and Protocols (2003), Humana Press Inc., Totowa, NJ
21. Joern J.M., Meinhold P., and Arnold F.H. Analysis of shuffled gene libraries. J. Mol. Biol. 316 (2002) 643-656
22. Joo H., Lin Z., and Arnold F.H. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation. Nature 399 (1999) 670-673
23. Kikuchi M., Ohnishi K., and Harayama S. Novel family shuffling methods for the in vitro evolution of enzymes. Gene 236 (1999) 159-167
24. Kim D., and Guengerich F.P. Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation. Biochemistry 43 (2004) 981-988
25. Moore J.C., Jin H.M., Kuchner O., and Arnold F.H. Strategies for the in vitro evolution of protein function: enzyme evolution by random recombination of improved sequences. J. Mol. Biol. 272 (1997) 336-347
26. Nakamura K., Martin M.V., and Guengerich F.P. Random mutagenesis of human cytochrome P450 2A6 and screening with indole oxidation products. Arch. Biochem. Biophys. 395 (2001) 25-31
27. Nelson D.R. Cytochrome P450 Nomenclature, 2004. In: Phillips I.R., and Shephard E.A. (Eds). Cytochrome P450 Protocols. Methods in Molecular Biology. 2nd ed. vol. 320 (2005), Humana Press Inc., Totawa, NJ 1-10
28. Nishihara K., Kanemori M., Kitagawa M., Yanagi H., and Yura T. Chaperone coexpression plasmids: differential and synergistic roles of DnaK-DnaJ-GrpE and GroEL-GroES in assisting folding of an allergen of Japanese cedar pollen, Cryj2, in Escherichia coli. Appl. Environ. Microbiol. 64 (1998) 1694-1699
29. Notley L.M., De Wolf C.J., Wunsch R.M., Lancaster R.G., and Gillam E.M.J. Bioactivation of tamoxifen by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 15 (2002) 614-622
30. Omura T. Forty years of cytochrome P450. Biochem. Biophys. Res. Commun. 266 (1999) 690-698
31. Parikh A., Gillam E.M.J., and Guengerich F.P. Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol. 15 (1997) 784-788
32. Parikh A., Josephy P.D., and Guengerich F.P. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties. Biochemistry 38 (1999) 5283-5289
33. Peters M.W., Meinhold P., Glieder A., and Arnold F.H. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. J. Am. Chem. Soc. 125 (2003) 13442-13450
34. Ridderstrom M., Zamora I., Fjellstrom O., and Andersson T.B. Analysis of selective regions in the active sites of human cytochromes P450, 2C8, 2C9, 2C18, and 2C19 homology models using GRID/CPCA. J. Med. Chem. 44 (2001) 4072-4081
35. Sowden R.J., Yasmin S., Rees N.H., Bell S.G., and Wong L.L. Biotransformation of the sesquiterpene (+)-valencene by cytochrome P450cam and P450BM-3. Org. Biomol. Chem. 3 (2005) 57-64
36. Stemmer W.P. DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 10747-10751
37. Stemmer W.P. Rapid evolution of a protein in vitro by DNA shuffling. Nature 370 (1994) 389-391
38. Williams J.A., et al. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab. Dispos. 32 (2004) 1201-1208
39. Yun C.H., Miller G.P., and Guengerich F.P. Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants. Biochemistry 39 (2000) 11319-11329
40. Zhao H., and Arnold F.H. Functional and nonfunctional mutations distinguished by random recombination of homologous genes. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7997-8000